Two Sigma Securities’s Park Ha Biological Technology Co BYAH Stock Holding History

Two Sigma Securities’s Portfolio BYAH Stock Details BYAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-40	Closed	-$2.52K	–	2304
2025 Q4	$2.52K	Sell	40 -27	-40%	-$3.27K	﹤0.01%	1366
2025 Q3	$12.8K	Buy	+67	New	+$83.3K	﹤0.01%	1190

Other funds holding BYAH

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Two Sigma Securities's BYAH Position: Q1 2026 in Review

Two Sigma Securities sold out of Park Ha Biological Technology Co (BYAH) in Q1 2026, closing a stake of 40 shares — an estimated $2.52K sold.

Two Sigma Securities first reported a position in BYAH in Q3 2025 and held it in 2 quarters. The position peaked at $12.8K in Q3 2025. 2 funds tracked by Wall St. Rank hold BYAH as of Q1 2026.

Two Sigma Securities reported no remaining Park Ha Biological Technology Co position as of Q1 2026 after selling out during the quarter.
Two Sigma Securities sold 40 Park Ha Biological Technology Co shares in Q1 2026, an estimated $2.52K.
Two Sigma Securities first reported a position in Park Ha Biological Technology Co in Q3 2025 and held it in 2 quarters.
Two Sigma Securities's Park Ha Biological Technology Co position peaked at $12.8K in Q3 2025.
2 funds tracked by Wall St. Rank held Park Ha Biological Technology Co as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.